Molecular mechanism of immune response requlated by HLA

HLA调节免疫反应的分子机制

基本信息

  • 批准号:
    05044177
  • 负责人:
  • 金额:
    $ 8.32万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for international Scientific Research
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1995
  • 项目状态:
    已结题

项目摘要

To investigate the molecular mechanism of immune response regulated by HLA,we investigated the T cell epitopes on HBs Ag, Cryptomeria Ag and HLA bound peptides eluted from HLA-A2, subtypes and HLA-B27 subtypes. Two antigenic T cell epitopes of Hepatitis B surface antigen (HBsAg), designated as HBs16-31 and HBs81-99, were identified.HBs16-31 was recognized by five HBsAg specific T cell lines from vaccinees with both high and low antibody titers, whereas HBs81-99 was recognized by two T cell lines derived from vaccinees with high antibody titers, suggesting taht HBs81-99 plays a critical role in anti-HBs antibody production in humans vaccinated with HBsAg. Japanese cedar pollinosis is a type I allergic disease caused by Japanese cedar (Cryptomeria japonica) pollen. The frequency of HLA-DP5 (DPA1^<**>02022 and DPB1^<**>0501) was significantly increased in the patients with Japanese cedar pollinosis. Using CPAg-specific T cell lines, we found that disease-associated HLA-DP5 restricted T ce … More lls specific for CPAg existed in the patients. Furthermore, an immunodominant peptide which induced HLA-DP5 restricted Th2 was identified. These observations suggest that the HLA-DP5 may be at least in part involved in the pathogenesis, by helping the IgE antibody production against CPAg. To investigate how single amino acid substitutions in MHC class I molecules affect differences in peptide repertoires, we cluted and sequenced the naturally processed peptides from three HLA-A2 subtypes (HLA-A^<**>0204, -A^<**>0206 and -A^<**>0207) which differ by a single amino acid residue substitution each with -A^<**>0201 at the floor of the binding groove. Allele-specific peptide-motifs for each HLA-A2 subtype substantially differed from that of -A^<**>0201 in the dominant anchor residues. The relative signal intensities for eighteen self peptides determined by mass spectrometry precisely reflected these peptide-motifs. According to the models, the differences in peptide-motifs could be explained by substituted-residue-driven conformational changes for each MHC-peptide complex. These results demonstrate the fine differences among HLA-A2 subtype self peptide repertoires and contribute to the prediction of antigenic peptides. Less
为了研究HLA调控免疫应答的分子机制,我们研究了从HLA- a2、亚型和HLA- b27亚型中洗脱的HBs Ag、Cryptomeria Ag和HLA结合肽上的T细胞表位。鉴定出乙型肝炎表面抗原(HBsAg)的两个抗原T细胞表位,分别为HBs16-31和HBs81-99。HBs16-31被来自高抗体滴度和低抗体滴度疫苗的5种HBsAg特异性T细胞系识别,而HBs81-99则被来自高抗体滴度疫苗的2种T细胞系识别,这表明HBs81-99在HBsAg疫苗接种人的抗hbs抗体产生中起关键作用。杉木花粉病是由杉木(Cryptomeria japonica)花粉引起的I型过敏性疾病。杉木花粉症患者HLA-DP5 (DPA1^<**>02022和DPB1^<**>0501)的频率显著升高。使用CPAg特异性T细胞系,我们发现疾病相关的HLA-DP5限制了T细胞的表达,患者体内存在更多CPAg特异性细胞。此外,还鉴定了一种诱导HLA-DP5限制性Th2的免疫优势肽。这些观察结果表明,HLA-DP5可能通过帮助产生针对CPAg的IgE抗体,至少部分参与了发病机制。为了研究MHC I类分子中单个氨基酸替换如何影响肽库的差异,我们对来自三种HLA-A2亚型(HLA-A^<**>0204, -A^<**>0206和-A^<**>0207)的天然加工肽进行了聚类和测序,这三种亚型在结合槽底部分别与-A^<**>0201进行了单个氨基酸残基替换。每个HLA-A2亚型的等位基因特异性肽基序在显性锚定残基上与-A^<**>0201有很大差异。质谱法测定的18种自肽的相对信号强度准确地反映了这些肽基序。根据这些模型,肽基的差异可以用取代残基驱动的构象变化来解释每个mhc肽复合物。这些结果证明了HLA-A2亚型自身肽库之间的细微差异,并有助于预测抗原肽。少

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mori K.: "Persistent elevation of immunoglobulin G titer against the C region of recombinant group A streptococcal M protein in patients with rheumatic fever" Pediatric Research. in press. (1996)
Mori K.:“风湿热患者中针对重组 A 组链球菌 M 蛋白 C 区的免疫球蛋白 G 滴度持续升高”儿科研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Satoh,M.,et al: "Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma." J.Rheumat.21. 111-114 (1994)
Satoh,M.,et al:“日本弥漫性硬皮病和局限性硬皮病患者之间的遗传和免疫学差异。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Wan XL.: "HLA-A and DRB4 genes in controlling the susceptibility to Hashimoto's Thyroiditis" Hum.Immunol.42. 131-136 (1995)
Wan XL.:“HLA-A和DRB4基因控制桥本甲状腺炎的易感性”Hum.Immunol.42。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamamoto,K.,et al: "Functional interaction between human histocompatibility leukocyte antigen(HLA)class II an mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice." J.Exp.Med.180. 165-171 (1994)
Yamamoto, K. 等人:“人类组织相容性白细胞抗原 (HLA) II 类与小鼠 CD4 分子在 HLA-DR 和 DQ 转基因小鼠 T 细胞抗原识别中的功能相互作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Dong,RP.,et al: "Characterization of T cell epitopes restricted by HLA-DP9 in streptococcal M12 prorein." J.Immunol.(in press).
Dong, RP., 等人:“链球菌 M12 蛋白中 HLA-DP9 限制的 T 细胞表位的表征。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SASAZUKI Takehiko其他文献

SASAZUKI Takehiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SASAZUKI Takehiko', 18)}}的其他基金

Immunogenetic Analysis of Autoimmune Thyroid Diseases
自身免疫性甲状腺疾病的免疫遗传学分析
  • 批准号:
    17019069
  • 财政年份:
    2005
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Mechanisms of oncogenesis and anti-oncogenesis
肿瘤发生和抗肿瘤发生的机制
  • 批准号:
    11178101
  • 财政年份:
    1999
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Development of soluble TCR and soluble MHC/peptide compelx with high affinity for their ligands
开发对其配体具有高亲和力的可溶性 TCR 和可溶性 MHC/肽复合物
  • 批准号:
    08557026
  • 财政年份:
    1996
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular Basis of Immunological Tolerance and Non-Response
免疫耐受和无反应的分子基础
  • 批准号:
    08044302
  • 财政年份:
    1996
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
in vitro manipulation of genes relevant to oncogenesis
体外操作与肿瘤发生相关的基因
  • 批准号:
    06454608
  • 财政年份:
    1994
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Molecular mechanism of immune regulation and immune tolerance
免疫调节与免疫耐受的分子机制
  • 批准号:
    05272103
  • 财政年份:
    1993
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Molecular mechanisms of immune regulation.
免疫调节的分子机制。
  • 批准号:
    05272104
  • 财政年份:
    1993
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Development of HLA bound peptitides which have supressive activity.
开发具有抑制活性的 HLA 结合肽。
  • 批准号:
    04557027
  • 财政年份:
    1992
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Research on the molecular basis for genetic control of immune response in human
人类免疫反应遗传调控的分子基础研究
  • 批准号:
    03404026
  • 财政年份:
    1991
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
Molecular Analyses of the Genetic Control of Immune Response in Humans
人类免疫反应遗传控制的分子分析
  • 批准号:
    63440028
  • 财政年份:
    1988
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)

相似海外基金

B cell development, autoimmunity and immune regulation
B 细胞发育、自身免疫和免疫调节
  • 批准号:
    MR/Y033701/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Research Grant
Innate immune regulation of lung inflammation through mitochondrial dynamics
通过线粒体动力学调节肺部炎症的先天免疫
  • 批准号:
    10659953
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Innate immune regulation by TSLP controls Strongyloides venezuelensis infection
TSLP 的先天免疫调节控制委内瑞拉类圆线虫感染
  • 批准号:
    23K06521
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
IMPORTANCE OF PERIODONTITIS IN THE INNATE IMMUNE REGULATION OF ALZHEIMER'S DISEASE
牙周炎在阿尔茨海默病先天免疫调节中的重要性
  • 批准号:
    10658447
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Chromatin and immune regulation of tumor growth and progression
肿瘤生长和进展的染色质和免疫调节
  • 批准号:
    10744436
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Nuclear Receptor Networks in Mucosal Immune Regulation
粘膜免疫调节中的核受体网络
  • 批准号:
    10822885
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease
人类和实验性炎症性肠病中雌激素介导的免疫调节
  • 批准号:
    10853530
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Immune Regulation of Dormancy at the Metastatic Site
转移部位休眠的免疫调节
  • 批准号:
    10744395
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Immune regulation to Coccidioides infection
对球孢子菌感染的免疫调节
  • 批准号:
    10731031
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Analysis of the mechanisms by which FPRs play a role in the immune regulation against cancer and organ transplantation and its application to treatments
FPRs在癌症和器官移植免疫调节中的作用机制分析及其在治疗中的应用
  • 批准号:
    23K08070
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了